Poland· PL-100449895
Bimatoprost + Timolol Genetic
A timolol, kombinationen product containing bimatoprostum + timololum, registered in Poland by Genetic S.p.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Timolol, kombinationen is registered in 12 of 19 countries.
Countries holding a registration under ATC S01ED51 (timolol, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Timolol, kombinationen · ATC S01ED51
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Bimatoprostum + Timololum
- Manufacturer
- Genetic S.p.A.
- Country
- Poland (PL)
- ATC code
- S01ED51
- ATC class
- Timolol, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991509170
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1 interaction on record for timolol, kombinationen.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Timolol, kombinationen · interactions on record
1 record
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Timolol, kombinationen in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBimatoprost 300micrograms/ml / Timolol 5mg/ml eye dropsAlliance Healthcare (Distribution) Ltd
- NetherlandsBimatoprost/Timolol axunio 0,3 mg/ml + 5 mg/ml oogdruppels, oplossingaxunio Pharma GmbH
- SpainBAPIRI 0,3 MG + 5 MG/ML COLIRIO EN SOLUCIONBrill Pharma S.L.
- GermanyBapiriTrb Chemedica Ag
- ItalyBIMATOPROST E TIMOLOLO TEVATEVA ITALIA S.R.L.
- CzechiaBIMATOPROST/TIMOLOL OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- FinlandBimatoprost/Timolol MylanMylan AB
- FranceBIMATOPROST/TIMOLOL BIOGARAN 0,3 mg/mL + 5 mg/mL, collyre en solutionBIOGARAN
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Bimatoprost/Timolol Genetic, Bimatoprost/Timolol Stada Arzneimittel Ag
- Belgium · Duelym, Ganzed
- Bulgaria · Бимасопт, Биматопрост Дуо
- Cyprus · Birmost-Co, Duelym
- Czechia · Bimatoprost/Timolol Olikla, Duelym
- Germany · Bapiri, Bimatoprost / Timolol Biogaran
- Denmark · Bimatoprost/Timolol Pharmathen, Bimatoprost/Timolol Stada
- Estonia · Bimatoprost/Timolol Elvim, Bimatoprost/Timolol Teva
- Spain · Bapiri, Bimatoprost/Timolol Stada
- Finland · Bimatoprost/Timolol Stada, Bitifrin
- France · Bimatoprost / Timolol Biogaran, Bimatoprost/Timolol Eg
- United Kingdom (Northern Ireland) · Bimatoprost + Timolol Blumont Pharma, Bimatoprost/Timolol Aspire
- Greece · Birmost-Co, Duelym
- Croatia · Duelym
- Ireland · Bitifrin, Duelym
- Iceland · Bimatoprost/Timolol Stada, Duelym
- Italy · Bimatoprost E Timololo Eg, Bimatoprost E Timololo Mylan
- Liechtenstein · Ganfort
- Lithuania · Bimatoprost/Timolol Elvim, Bimatoprost/Timolol Teva
- Luxembourg · Duelym, Ganzed
- Latvia · Bapiri, Bimatoprost/Timolol Elvim
- Netherlands · Bimatoprost/Timolol Axunio, Bimatoprost/Timolol Blumont
- Norway · Bimabloc, Bimtim
- Portugal · Eduelym, Ibrigan
- Romania · Bimatoprost/Timolol Rompharm, Duelym
- Sweden · Bimabloc, Bimatoprost/Timolol Brown & Burk
- Slovakia · Bimatoprost/Timolol Olikla, Duelym
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d41a4775-21e6-4223-9397-fe652303de25 GET /v1/drugs/d41a4775-21e6-4223-9397-fe652303de25?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Krople do oczu, roztwór",
"source": "urpl",
"strength": "0,3 mg/ml + 5 mg/ml",
"packaging": "05909991509170 ¦ Rp ¦ 149175\n1 butelka 3 ml",
"substance": "Bimatoprostum 0.3 mg/ml + Timololi maleas 6.83 mg/ml",
"common_name": "Bimatoprostum + Timololum",
"pl_product_id": "100449895",
"pozwolenie_nr": "27699",
"auth_procedure": "DCP",
"authorisation_validity": "2025-06-03"
}See everything about timolol, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.